Related Experiment Video
Updated: Jun 5, 2026

09:45
Modification and Functionalization of the Guanidine Group by Tailor-made Precursors
Published on: April 27, 2017
1,3-Dicyclo-hexyl-1-isonicotinoylurea monohydrate.
Acta Crystallographica. Section E, Structure Reports Online
|January 5, 2011
Summary
Researchers synthesized a novel organic compound, C(19)H(27)N(3)O(2)·H(2)O. This compound forms a unique 2D supra-molecular structure linked by hydrogen bonds involving water molecules.
Area of Science:
- Supramolecular Chemistry
- Organic Synthesis
- Crystallography
Background:
- Understanding the self-assembly of organic molecules is crucial for designing advanced materials.
- Hydrogen bonding plays a key role in directing the formation of ordered supramolecular architectures.
- The synthesis and characterization of novel organic compounds with unique structural motifs are of significant interest.
Purpose of the Study:
- To synthesize a new organic compound with the molecular formula C(19)H(27)N(3)O(2)·H(2)O.
- To investigate the self-assembly behavior of the synthesized compound in the solid state.
- To elucidate the role of water molecules in the formation of supramolecular structures.
Main Methods:
- Organic synthesis involving methyl-ene dicyclo-hexyl-amine, 4-pyridine-carboxylic acid, and N,N'-dicyclo-hexyl-carbodiimide.
- Single-crystal X-ray diffraction to determine the molecular and crystal structure.
- Analysis of intermolecular interactions, particularly hydrogen bonding.
Main Results:
- Successful synthesis of the target organic compound C(19)H(27)N(3)O(2)·H(2)O.
- The crystal structure revealed the presence of a water molecule.
- The water molecule mediates intermolecular hydrogen bonds, linking urea molecules into a 2D ladder-like supramolecular structure.
Conclusions:
- A novel organic compound was synthesized and its structure characterized.
- The compound exhibits a unique two-dimensional supramolecular architecture driven by hydrogen bonding.
- This study highlights the importance of solvent molecules in directing supramolecular assembly.
More Related Videos
Related Concept Videos
Oral Hypoglycemic Agents: Sulfonylureas
Sulfonylureas are oral hypoglycemic agents utilized in treating type 2 diabetes. They are characterized by their unique sulfonylurea chemical structure. The family of sulfonylureas is divided into generations. First-generation sulfonylureas, including tolbutamide (Orinase), chlorpropamide (Diabinese), and tolazamide (Tolinase), trigger insulin release from pancreatic β cells and enhance peripheral tissues' insulin sensitivity. The second-generation members, such as glipizide (Glucotrol),...
Nomenclature of Carboxylic Acid Derivatives: Amides and Nitriles
Naming Amides
The IUPAC and common names of amides are derived from the parent carboxylic acid, by replacing the suffix “oic acid” and “ic acid,” respectively, with “amide.” In the following example, the IUPAC name ethanamide is derived from ethanoic acid, and the common name, acetamide, is obtained from acetic acid.
The IUPAC and common names of amides are derived from the parent carboxylic acid, by replacing the suffix “oic acid” and “ic acid,” respectively, with “amide.” In the following example, the IUPAC name ethanamide is derived from ethanoic acid, and the common name, acetamide, is obtained from acetic acid.
Oral Hypoglycemic Agents: Glinides
Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively manages...
Dipeptidyl Peptidase 4 Inhibitors
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a significant...
Hypoglycemia
Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...

